Trials / Active Not Recruiting
Active Not RecruitingNCT05492994
A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease
Longitudinal Study Without an Investigational Medicinal Product in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to Evaluate Novel Imaging-based Biomarkers in Comparison With Lung Function for Use in Early Clinical Development
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The main objectives of this imaging biomarker study are to assess the annual lung function change in patients with progressive fibrosing interstitial lung disease (PF-ILD) including idiopathic pulmonary fibrosis (IPF), with Usual Interstitial Pneumonia (UIP) or probable UIP Computer Tomography (CT) pattern, and to monitor lung structural changes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Spirometry | Pulmonary function test |
| DIAGNOSTIC_TEST | Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) | Pulmonary function test |
| DIAGNOSTIC_TEST | Magnetic Resonance Imaging | Magnetic Resonance Imaging |
| DIAGNOSTIC_TEST | Chest Computer Tomography | Chest Computer Tomography |
| DIAGNOSTIC_TEST | Blood biomarker analysis | Blood biomarker analysis |
Timeline
- Start date
- 2022-12-19
- Primary completion
- 2026-06-09
- Completion
- 2026-06-09
- First posted
- 2022-08-09
- Last updated
- 2025-08-05
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05492994. Inclusion in this directory is not an endorsement.